FDA-Cleared Utepreva Device Aims to Improve Early Endometrial Cancer Detection
Cancer
CellCarta Secures Global Exclusivity for Aspyre Lung to Advance Lung Cancer Testing
Non-Surgical Skin Cancer Treatment Achieves 99% Cure Rate
Location of T Cells Could Revolutionize Immunotherapy Success in Lung Cancer
Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
Pfizer Announces Positive Phase 2b Outcomes for Obesity Drug Candidate, Danuglipron
First-Ever Obstructive Sleep Apnea Drug, Zepbound, Approved by FDA for Obesity
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
